Skip to content

A study to compare efficacy of Triphaladi Ghrita Aschyotana versus Payasaindhava Parishek in Dry Eye Syndrome(Shushkakshipaka)

Efficacy of Triphaladi Ghrita Aschyotana and Paya Saindhava Parisheka in the Management of Shushkakshipaka with Special Reference to Dry Eye Syndrome: A Comparative Clinical Study. - ETGAP-SK

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112388
Enrollment
64
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Sponsors

Dr Priyanka Baghel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having classical signs and symptoms of Shushkakshipaka 2. SchirmerI test positive i.e. less then 15 mm 3. Tear film Break up time less then 15 second 4. Eligible cases for Aschyotana and Parishek

Exclusion criteria

Exclusion criteria: 1. Age Below 18 years and above 60 years were excluded. 2. Shushkakshipaka is associated with other specific ocular diseases such as Savrana Shukla (corneal ulcer), acute conjunctivitis, chronic viral infections, and allergic condition. 3. Traumatic eye injury and Recent eye surgery. 4. Severe cases of dry eye disease with complications like perforated corneal ulcer, Uveitis, Glaucoma. 5. Patients who were contraindicated for Aschyotana and Pariseka.

Design outcomes

Primary

MeasureTime frame
Improvement In Tear Film Break-Up Time (TBUT) and Schirmer s Test Improvement in Tear Film Break-Up Time (TBUT) and Schirmer s Test values.alues.Timepoint: Baseline - (Before Treatment) 3 Weeks, 4 Weeks , 8 Weeks

Secondary

MeasureTime frame
Additional benefits in reducing ocular discomfortTimepoint: Secondary outcomes were assessed at baseline (Day 0), during treatment (Day 7 and Day 14), at the end of treatment (Day 21), and at follow-up (1 2 weeks after completion of therapy.

Countries

India

Contacts

Public ContactDr Priyanka Baghel

JK Town Sarvadharam CSector Kolar Road Bhopal

shilpsanup@gmail.com9584045869

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026